Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/27/2010CN101869563A Peptide deformylase inhibitor containing 4-methylene pyrrolidine
10/27/2010CN101869562A Levamlodipine compound medicinal preparation
10/27/2010CN101869561A Tacrolimus-containing improved release composition
10/27/2010CN101869560A Isoalantolactone amino derivative and application of salt thereof in preparing anti-tumor medicament
10/27/2010CN101869559A Application of gartanin compound in preparing medicaments for treating hyperlipidemia
10/27/2010CN101869558A Anti-angiogenesis and anti-metastasis effect of diacetyldianhydrogalactitol
10/27/2010CN101869557A Application of nordihydroguaiaretic acid in preparing drug capable of resisting tumour stem cells
10/27/2010CN101869556A Uncaria slow release capsule preparation and preparation method thereof
10/27/2010CN101869555A Nifedipine controlled -release tablet and preparation technology thereof
10/27/2010CN101869554A Doxazosin mesylate controlled release tablet and preparation technology thereof
10/27/2010CN101869553A Bupropion hydrochloride sustained release tablets and preparation method thereof
10/27/2010CN101869552A Preparation method of chitin tablet
10/27/2010CN101869551A Temozolomide freeze-dried preparation
10/27/2010CN101869550A Oral sustained-release dry suspension taking clarithromycin as main ingredient
10/27/2010CN101869549A Oral sustained-release dry suspension taking roxithromycin as main ingredient
10/27/2010CN101869548A Oral sustained-release dry suspension taking azithromycin as main ingredient
10/27/2010CN101869547A Tacrolimus injection preparation
10/27/2010CN101869546A Supermolecular gel used for protecting photostability of vitamin A derivatives
10/27/2010CN101869545A Preparation method of embedded drug-loaded glucomannan and xanthan gum composite gel
10/27/2010CN101869544A Ambroxol hydrochloride controlled release suspension and preparation method thereof
10/27/2010CN101869283A Assistant hypoglycemia healthcare food of mulberry-leaf extract and preparation method thereof
10/27/2010CN101869157A Health-care composition (Parkinson-resistant shockproof health-care tea) for preventing and treating PD (Parkinson Disease) and preparation method thereof
10/27/2010CN101708249B Buccal tablets used for treating wind-heat acute pharyngitis
10/27/2010CN101584705B Medicament composition for treating diabetes and complications of diabetes
10/27/2010CN101579341B Novel use of pantoprazole sodium in treatment of cholecystitis
10/27/2010CN101574328B Timing pulsed release micro-pill of zolpidem salt
10/27/2010CN101564389B Application of arbidol hydrochloride in preparing medicine for preventing and treating canine distemper virus
10/27/2010CN101518513B Cinepazide maleate lipid microspheres preparation and preparation method thereof
10/27/2010CN101496803B Application of compound taurine and ansiolin in preparing medicament for treating brain injury disease
10/27/2010CN101444508B Tropisetron preparation for injection and preparation method thereof
10/27/2010CN101439036B Pharmaceutical composition containing 18 kinds of amino acid
10/27/2010CN101396355B Use of bilobalide B in preparing medicine for promoting nerve cell regenerate
10/27/2010CN101336897B Preparation method and use of stable o-methylhydroquione
10/27/2010CN101322718B Injection for reducing drug dependency and preparation thereof
10/27/2010CN101301422B Chinese medicinal composition for treating mastitis of milk cattle and preparation and application thereof
10/27/2010CN101284124B Attapulgite alcohol group kibe formulations
10/27/2010CN101274095B Humic acid detoxification peptide compound preparation and method for preparing the same
10/27/2010CN101264087B Medicinal composition containing cefpodoxime proxetil cyclodextrin inclusion compound and preparation thereof
10/27/2010CN101239094B Active component composition used as adjuvant drug for antitumor and preparation and application thereof
10/27/2010CN101234118B Medicinal composition for treating cardiovascular and cerebrovascular diseases
10/27/2010CN101229172B Solid dispersing agent of glycyrrhetinic acid 30-acylamide derivatives, preparing method and uses thereof
10/27/2010CN101181247B Biphenyl benzyl azoles aerosol and preparation method thereof
10/27/2010CN101181232B Marseilledinun sustained-release implantation agent for curing entity tumour
10/27/2010CN101175738B Apoptosis promoters
10/27/2010CN101156877B A sobering-up agent
10/27/2010CN101148443B Medicine for treating and preventing oral disease
10/27/2010CN101102773B Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases
10/27/2010CN101088521B Astragalus medicine prepn and its prepn process
10/27/2010CN101085216B Composition containing biological polysaccharide and biological polysaccharide wine made from the same
10/27/2010CN101052639B Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/27/2010CN101031310B Ophthalmic composition containing xanthan gum and amino acid
10/27/2010CN101027309B Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
10/27/2010CN101018554B Topical compositions containing phosphorylated polyphenols
10/26/2010USRE41895 Epothilone derivatives
10/26/2010USRE41894 Hepatitis C inhibitor tri-peptides
10/26/2010USRE41893 Epothilone derivatives
10/26/2010USRE41883 contains at least about 5% of an aromatic ester emollient or a fatty alcohol ester of a non-fatty organic acid emollient or mixture thereof, and from about 25% to about 95% of a retention/release agent, wherein substrate is chosen from a towel or tissue
10/26/2010US7820857 administering (R)-2-acetamido-N-benzyl-3-methoxypropionamide for treating neuropathic trigeminal pain
10/26/2010US7820839 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
10/26/2010US7820834 Triptolide 5,6-derivatives as immunomodulators and anticancer agents
10/26/2010US7820829 1,2-Bis[(1,2)-benzisoselenazol-3(2H)-onyl]ethane; high anti-oxidative activity and low toxicity; in combination with other anticarcinogenic, anticoagulant, antiinflammatory agents ( cisplatin, adriamycin, taxol; aspirin; indometacin)
10/26/2010US7820827 3,4-disubstituted-4-aryl-piperidine; treating pain with opioids while avoiding side effects such as constipation, nausea and vomiting by administering said compounds; treating gastrointestinal disorders such as ileus (bowel obstruction)
10/26/2010US7820826 for modulating nicotinic acetylcholine receptors;
10/26/2010US7820825 N-substituted-azacyclylamines as histamine-3 antagonists
10/26/2010US7820823 Dual action antibiotics
10/26/2010US7820821 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820818 Inhibitors of cathepsin K; inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors; 4-Cyclopentylamino-5-(4-phenyl-but-1-ynyl)-pyrimidine-2-carbonitrile; 5-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-prop-1-ynyl]-4-(2,2-dimethyl-propylamino)-pyrimidine-2-carbonitrile
10/26/2010US7820817 substituted piperazine compounds that are useful modulators of muscarinic receptors; 1-(5-bicyclo[2.2.1]hept-2-enylmethyl)-4-(3-nitro-2-pyridyl)-piperazine; treatment of COPD, asthma, urinary incontinence, glaucoma, Alzheimer's (AchE inhibitors), and pain
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820811 [(3aR,4R,6R,6aR)-6-(6-amino-2-methoxy-9H-purin-9yl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methanol; improved oral absorption
10/26/2010US7820809 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition
10/26/2010US7820804 increases the effect on Sodium-dependent glucose cotransporters (SGLT); for lowering blood glucose; treatment of type 1 and type 2 diabetes; N-(2-Carbamoylethyl)-4-[1-(2-cyano-ethyl)-5-hydroxy-3-isopropyl-1H-pyrazol-4-ylmethyl]benzamide
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820788 injection comprising paclitaxel and albumin to reduce side effects; drugs such as propofol or paclitaxel; for cancer, arthritis, or restenosis
10/26/2010US7820784 polypeptides that stimulate the formation and cycling of pre-beta high density lipoproteins, promote lipid transport and detoxification, inhibit osteoporosis and atherosclerosis, intensify the activity anticholesterol agents, causing them to be significantly more antiinflammatory at any given dosage
10/26/2010US7820759 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820721 [4-(3-(2,6-Dimethylbenzyloxy)-phenyl)-4-hydroxybutan-ol; 1-(3-(2,6-Dimethylbenzyloxy)phenyl)-4-hydroxybutan-1-one; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
10/26/2010US7820720 antifungal formulations comprising terbinafine or a pharmaceutically acceptable salt thereof, a lipid, and a surfactant; uses thereof for the treatment of skin and nail fungal infections
10/26/2010US7820719 exposing pancreatic cancer cell to a concentration of less than 100 mu g/ml of a drug substance selected from a product of polycondensation between a guanidine acid addition salt and a diamine compound comprising an oxyalkylene chain between two amino groups and a pharmaceutically acceptable salt thereof
10/26/2010US7820718 inhibiting growth of a tumor comprising head and neck squamous carcinoma cells by contacting the tumor with an amount of paclitaxel, and an amount of C6-ceramide, sequentially or concomitantly
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820716 Forms V and F; thermal stability, material flow character, lower water content; reproducible pharmaceutical formulations
10/26/2010US7820715 Chemical intermediates; neurodegenerative disorders
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/26/2010US7820713 Cocoa extracts as antioxidants
10/26/2010US7820712 Uses of ion channel modulating compounds
10/26/2010US7820711 Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders
10/26/2010US7820708 Carboxamides
10/26/2010US7820707 Heterocyclic derivatives
10/26/2010US7820706 Inducing ovulation in a female suffering from anovulatory infertility by administering two or more daily doses of at least one aromatase inhibitor
10/26/2010US7820705 Compounds and compositions as PPAR modulators
10/26/2010US7820704 Substituted heteroaryl derivatives, compositions, and methods of use
10/26/2010US7820703 enhancing wound repair; treating reperfusion type injury; lyso-lipid phosphate phosphatase inhibitor; phosphoric acid mono-[3-(4-phenyloxy-pyrimidine)-2-octadec-9-enoylamino-propyl] ester or salt
10/26/2010US7820702 Sulfonylpyrrolidine modulators of androgen receptor function and method
10/26/2010US7820701 having a purity of at least 95% pure, preferably at least about 97% pure, more preferably at least at least about 99.5% pure; providing rapid relief from hypertension
10/26/2010US7820700 2-phenylpyridine derivative
10/26/2010US7820699 5-Chloro-thiophene-2-carboxylic acid ((3S ,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide; anticoagulant, inhibit coagulation factor Xa
10/26/2010US7820698 3,5-dichloro-pyridin-4-ylmethyl)-(3,4-dimethoxy-phenyl)-(4-fluoro-benzyl)-amine; treating diseases involving inflammation, such as asthma or arthritis, or diseases of the central nervous such as cognitive decline or memory loss
1 ... 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 ... 7860